GEO GROUP INC Q3 FY2024 earnings call

Management Statement and Operational Highlights

• Financial Performance: In Q3 2024, net income attributable to GEO was approximately $26 million or $0.19 per diluted share on revenues of ~$603 million. Adjusted net income was ~$29 million or $0.21 per diluted share. Secured services revenue increased 6% YOY, offset by EMSS revenue decline.
• Debt Reduction: Year-to-date, net debt has been reduced by approximately $92 million. Aim to reduce net debt by an additional ~$20 million in Q4 2024, bringing total net debt to ~$1.67 billion by year-end. Fixed rate debt represents ~76% of total indebtedness.
• Operational Milestones: Secure Services facilities had 61 audits, renewals of several ICE processing center contracts. EMSS has provided monitoring services under ISAP for almost 20 years, with the rebid procurement for ISAP expected in May 2025.

Segment Performance

• Secure Services: Owned and leased secure services facilities saw a ~6% year-over-year revenue increase primarily due to higher occupancy at ICE facilities. There are approximately 10,000 available beds at six company-owned idle facilities and ~8,000 underutilized beds under contract, which could generate incremental annualized revenues if fully utilized. Additionally, secure services facilities underwent audits, renewals, and contract extensions, and the division provides various ancillary services like secure transportation.
• Electronic Monitoring and Supervision Services (EMSS): Revenues declined year-over-year due to lower participant counts under the ISAP contract. However, EMSS has the technology and staffing resources to scale up supervision services. Current ISAP participant count is ~182,500, with potential to scale up to several million participants. EMSS has a 20-year track record under ISAP with bipartisan support.

Guidance

• Fourth Quarter 2024: Expected net income attributable to GEO to be in the range of $0.19 to $0.22 per diluted share on quarterly revenues of ~$600 million to $610 million. Expected adjusted EBITDA to be in the range of $114 million to $124 million.
• Full Year 2024: Expected net income attributable to GEO to be in the range of $0.30 to $0.34 per diluted share. Excluding non-recurring items, expected adjusted net income to be in the range of $0.80 to $0.84 per diluted share on revenues of ~$2.42 billion. Expected adjusted EBITDA to be between $470 million and $480 million.

Risks

• Uncertainty in federal funding post-continuing resolution expiration on December 20. Congress may extend the continuing resolution, but future funding levels are uncertain.
• Potential changes in government policies affecting contract renewals and funding for ICE, Marshals, and other programs.
• Dependence on specific government contracts and the lengthy process of rebid procurements for contracts like ISAP.

Q: Heard commentary about ISAP potentially scaling up to millions, but curious about NOI margins. How do margins trend?

A: Margins move with service mix, including technology and case management. Expect margins to be at least consistent with current levels and potentially improve.

Q: Talked about air services contract. Size of opportunity and margins?

A: Theoretical potential doubling of services, depending on Congress funding. Margins depend on service mix, but seen as an unprecedented opportunity.

Q: Year-over-year revenue and net operating income decline in EMSS. Explain.

A: Due to mix changes in services, including different margin levels and staffing requirements for case management services.

Q: Debt reduction goals. Update on progress.

A: On track to reduce net debt by ~$112 million in 2024, with goal of $150M-$175M annual reduction, considering one-time fees for debt restructuring.

Q: ISAP contract capacity and CapEx. What's needed to scale up?

A: CapEx depends on monitoring devices used. Exclusive provider under ISAP with broad footprint and integrated capabilities.

Q: Scale opportunity and impact on leverage and capital return. Posture?

A: Will be thoughtful about long-term needs, may redirect contracts towards federal purposes and evaluate facility expansion carefully.

Q: ICE population increase and facility startup challenges. Staffing and CapEx?

A: Startup costs include physical plant renovations and labor recruitment. Federal contracts have market rate labor, but clearance processes may delay startup.

Q: Trump administration impact on BOP contracts. Priority and terms?

A: Short-term priority for ICE, long-term opportunities for BOP as prior Biden policy is reversed. Terms depend on contracting process.

Q: ISAP contract expiration and extension. Timeline?

A: Contract expires in May 2025, can be extended for up to 18 months. New administration may delay RFP process for new contract.